Clinical Trial Update: Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers [Phase 4]

View source ↗

Summary

A Phase 4 pharmacodynamic study update evaluating the therapeutic response and immunomodulatory effects of Avonex in multiple sclerosis patients and healthy vol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED